CDH1 and cancer: Previous clinical studies in human cancers, including NSCLCs, also have demonstrated that dysfunction of E-cadherin/catenin complex is associated with dedifferentiation (Bohm et al, 1994), lymph node metastasis (Sulzer et al, 1998), and a poor prognosis (Sulzer et al, 1998).